15th Jun 2016 07:40
LONDON (Alliance News) - Eden Research PLC on Wednesday said it has been granted label extensions for the use of grapevine treatment 3AEY for a new disease target in Spain and a number of additional minor uses in Greece.
3AEY had originally been designated for the prevention and treatment of the fungus botrytis in table and wine grapes, but the label extensions will now allow it to be used for other purposes alongside Eden's commercialisation partners Sipcam Iberia in Spain and Redestos Group in Greece.
In Spain, 3AEY has been additionally approved for use in the control of vine powdery mildew, which is also a fungal disease of grapevines.
In Greece, the authorities have expanded approval for the treatment of botrytis in field and greenhouse aubergines, kiwis, pomegranates and fresh onions.
"These approvals are the first milestone in the expansion of regulatory clearance for 3AEY outside of the initial authorisation for the prevention and cure of botrytis on table and wine grapes. Together with Redestos Group, Eden is also pursuing authorisation for 3AEY in several countries outside of the EU Southern Zone, and these registrations will be granted in due course, subject to regulatory process and approval," Eden said in a statement.
Eden provides natural microencapsulation technologies to the agrochemical, animal health and consumer product industries.
Shares in Eden were trading up 4.9% at 9.18 pence on Wednesday morning.
By Karolina Kaminska; [email protected] @KarolinaAllNews
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Eden